期刊
BIOMATERIALS ADVANCES
卷 133, 期 -, 页码 -出版社
ELSEVIER
DOI: 10.1016/j.msec.2021.112613
关键词
Diabetes; Bone mesenchymal stem cell; Exosomes; Hydrogel
资金
- Project of Liaoning Educational Committee [JYTJCZR2020067, JYTQN2020015]
Chronic diabetic wound injury is a serious complication of diabetes, and effective treatment is crucial. In this study, a novel hydrogel loaded with bone marrow mesenchymal stem cell-derived exosomes was designed for chronic diabetic wound healing. The hydrogel promoted angiogenesis and adjusted the wound inflammation microenvironment to accelerate wound healing.
Chronic diabetic wound injury is a serious syndrome of diabetes, and the treatment of this syndrome is of great significance. Owing to metabolic abnormalities, diabetic wounds are difficult to heal due to chronic inflammation, immune dysfunction, impaired angiogenesis and bacterial reproduction. However, most traditional treatments can only play a limited role in dealing with unhealed wounds, and the overall healing effect is not ideal. We designed a novel bone marrow mesenchymal stem cell-derived exosome (MSC-Exo)-loaded carboxyethyl chitosan (CEC)-dialdehyde carboxymethyl cellulose (DCMC) hydrogel (MSC-Exos@CEC-DCMC HG) for chronic diabetic wound healing. The results demonstrated that CEC can be cross-linked with DCMC through Schiff base reactions to form antibacterial and selfhealing hydrogels. The inherent MSC-Exos not only promoted angiogenesis but also enhanced the transformation of M1-type macrophages to the M2 type to reduce inflammatory effects. Finally, MSC-Exos@CEC-DCMC HG, as an effective therapeutic agent, synergistically adjusted the wound inflammation microenvironment, promoted neovascularization, and accelerated wound healing in type 1 diabetic rats.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据